Results 231 to 240 of about 359,969 (268)
Some of the next articles are maybe not open access.
BENIGN PROSTATIC HYPERPLASIA (THE AGING PROSTATE)
Medical Clinics of North America, 1999BPH is a common phenomenon of the aging process. Clinical manifestations may range from minimally bothersome symptoms to urinary retention and renal failure. Tailoring of treatment based on the individual patient is required for successful management. For mild symptoms, watchful waiting is a valid option.
J J, Medina, R O, Parra, R G, Moore
openaire +2 more sources
Epidemiology of clinical benign prostatic hyperplasia
Asian Journal of Urology, 2017 Clinical benign prostatic hyperplasia (BPH) is one of the most common diseases in ageing men and the most common cause of lower urinary tract symptoms (LUTS).
Kok Bin Lim
exaly +2 more sources
The American Journal of the Medical Sciences, 1997
Benign prostatic hyperplasia is a common and costly disease that affects older men. This article reviews the underlying histopathologic changes that cause benign prostatic hyperplasia. The symptoms and systematic evaluation of the patient are described, along with the current therapeutic options for treatment.
openaire +2 more sources
Benign prostatic hyperplasia is a common and costly disease that affects older men. This article reviews the underlying histopathologic changes that cause benign prostatic hyperplasia. The symptoms and systematic evaluation of the patient are described, along with the current therapeutic options for treatment.
openaire +2 more sources
Medicina Clínica (English Edition)
Benign prostatic hyperplasia (BPH) is a histopathologic definition associated with enlargement of the prostate gland that causes obstruction of the lower urinary tract and manifests clinically with characteristic symptoms that are what bring patients for consultation.
Sarelis, Infante Hernández +2 more
openaire +2 more sources
Benign prostatic hyperplasia (BPH) is a histopathologic definition associated with enlargement of the prostate gland that causes obstruction of the lower urinary tract and manifests clinically with characteristic symptoms that are what bring patients for consultation.
Sarelis, Infante Hernández +2 more
openaire +2 more sources
Tamsulosin for benign prostatic hyperplasia
Cochrane Database of Systematic Reviews, 2002Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate which can result in bothersome lower urinary tract symptoms. The treatment goal for men with BPH is to relieve these bothersome symptoms.This systematic review assessed the effects of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) compatible with BPH ...
T J, Wilt, R, Mac Donald, I, Rutks
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2019
Benign prostatic hyperplasia (BPH) is a common condition in aging men that is frequently associated with troublesome lower urinary tract symptoms (LUTS). The American Urologic Association Symptom Index is a validated, self-administered tool that is used to diagnose LUTS, guide initial treatment, and assess treatment response.
openaire +2 more sources
Benign prostatic hyperplasia (BPH) is a common condition in aging men that is frequently associated with troublesome lower urinary tract symptoms (LUTS). The American Urologic Association Symptom Index is a validated, self-administered tool that is used to diagnose LUTS, guide initial treatment, and assess treatment response.
openaire +2 more sources
Testosterone and Benign Prostatic Hyperplasia
Sexual Medicine Reviews, 2019Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) are frequent in aging. Nonetheless, their pathogenesis is largely unknown. The androgen dependence of the first phases of prostate development have inspired the historical view that higher testosterone (T) may be involved in BPH occurrence; however, recent evidence suggests a ...
Giulia Rastrelli +2 more
exaly +4 more sources
Phytotherapy for Benign Prostatic Hyperplasia
Current Urology Reports, 2016The use of complementary and alternative medications for symptomatic benign prostatic hyperplasia is a lucrative business in the USA with revenues reaching close to US$6.4 billion in sales for the 2014 fiscal year. Yet, despite its popularity, the evidence supporting the continued use of phytotherapy for symptomatic benign prostatic hyperplasia (BPH ...
Aryeh, Keehn +2 more
openaire +2 more sources
Clinics in Geriatric Medicine, 2010
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies.
openaire +2 more sources
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies.
openaire +2 more sources
Finasteride for benign prostatic hyperplasia
Cochrane Database of Systematic Reviews, 2009Benign prostatic hyperplasia (BPH), a non-malignant enlargement of the prostate in aging men, can cause bothersome urinary symptoms (intermittency, weak stream, straining, urgency, frequency, incomplete emptying). Finasteride, a five-alpha reductase inhibitor (5ARI), blocks the conversion of testosterone to dihydrotestosterone, reduces prostate size ...
James, Tacklind +4 more
openaire +2 more sources